Home
Yaoyanshe

Yaoyanshe Market Share Analysis for June 2026

药研社是专注为制药企业提供创新型药物研发服务的科技平台。围绕人才、数据的核心优势，通过科技手段建立cro/smo服务的标准化和流程化，整体缩短周期20%，平均降低成本15%，让医药研发更高效。

Industry: N/A

Domainyaoyanshe.com

Year Founded2015

Employees501 - 1000

Annual Revenue$2M - $5M

Yaoyanshe

Yaoyanshe (including company regionals)

yaoyanshe.com

See more website traffic and engagement information

Yaoyanshe Revenue up to June 2026 is 2M - 5M

revenue generated by Yaoyanshe top domains

Yaoyanshe top domains revenue over 3 years

Revenue for Yaoyanshe top domains

yaoyanshe.com2M - 5M

See more with Sales Intelligence

Total visits to Yaoyanshe's top domains

Understand Yaoyanshe market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Yaoyanshe's top domains

Analyze Yaoyanshe engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Yaoyanshe's top domains

See how Yaoyanshe keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Yaoyanshe top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Yaoyanshe

These are the website technologies, by industry, used by Yaoyanshe top domains

Mobile (3)

Meta Viewport

Advertising (2)

PubMatic

Conversion & Analytics (1)

Baidu Analytics

Multilingual (1)

Multilingual Support

News & Signals from Yaoyanshe

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsYaoyanshe receives financing of $86.4M in two rounds.Yaoyanshe, a Chinese contract research organization (CRO) for novel drugs, has raised RMB600 million ($86 million) across two rounds in the past eight months.

NewsYaoyanshe receives financing of $42M in C funding round.Yaoyanshe, a Shanghai online AI-based CRO/CMO, raised $42 million in a C funding round led by Eastern Bell Capital and Sequoia China.